Published in Glycoconj J on December 01, 1999
Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. PLoS One (2008) 1.30
Evaluation of biological safety in vitro and immunogenicity in vivo of recombinant Escherichia coli Shiga toxoids as candidate vaccines in cattle. Vet Res (2015) 0.76
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy. Int J Oncol (2015) 0.76
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem (1987) 3.71
Membrane microdomains and caveolae. Curr Opin Cell Biol (1999) 3.34
Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem (1990) 3.02
Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem (1987) 3.00
Life and death in germinal centers (redux). Immunity (1996) 2.91
The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol (1995) 2.64
Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature (1992) 2.49
A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med (1999) 2.42
Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry (1998) 2.38
Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms. Anal Biochem (1980) 2.29
The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol (1992) 2.17
Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem (1989) 2.12
Role of verotoxin receptors in pathogenesis. Trends Microbiol (1996) 1.95
Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J Immunol (1987) 1.60
A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science (1983) 1.51
Verotoxin-binding in human renal sections. Nephron (1994) 1.47
Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem (1987) 1.34
Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. J Biol Chem (1999) 1.34
Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res (1993) 1.31
GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells. J Biol Chem (1998) 1.27
Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc Natl Acad Sci U S A (1990) 1.27
IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J Immunol (1993) 1.26
CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. J Biol Chem (1998) 1.26
CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J Immunol (1999) 1.13
Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells. Blood (1997) 1.11
Cytoskeletal association of human alpha-interferon-receptor complexes in interferon-sensitive and -resistant lymphoblastoid cells. Proc Natl Acad Sci U S A (1987) 1.06
Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol (1998) 1.05
Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. Semin Immunol (1996) 1.03
The functional role of B cell antigen receptor stimulation and IL-4 in the generation of human memory B cells from germinal center B cells. J Immunol (1997) 0.98
Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells. Mol Biol Cell (1996) 0.95
Globotriaosyl ceramide (Gb3) expression in human tumour cells: intracellular trafficking defines a new retrograde transport pathway from the cell surface to the nucleus, which correlates with sensitivity to verotoxin. Acta Biochim Pol (1998) 0.94
Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. Chem Biol (1996) 0.93
Alpha-interferon inhibits the expression of heavy chain mu messenger RNA in Daudi cells. EMBO J (1988) 0.93
Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms. Immunology (1991) 0.92
CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis. J Cell Physiol (1998) 0.90
Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin. Eur J Immunol (1998) 0.88
Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus. Int J Cancer (1988) 0.88
Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells. Int J Cancer (1985) 0.85
Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity. J Cell Physiol (2000) 0.84
Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit. Biochem J (1992) 0.81
Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade. J Immunol (1998) 0.81
Evidence for glycosphingolipid modification of the type 1 IFN receptor. J Immunol (1994) 0.80
Up-regulation of neutral glycosphingolipid synthesis upon long term inhibition of ceramide synthesis by fumonisin B1. J Biol Chem (1999) 0.79
DNA synthesis in nuclei isolated from Daudi B cells: a model to study the antiproliferative mechanisms of interferon-alpha. J Interferon Res (1992) 0.79
Functional properties of human germinal center B cells. Cell Immunol (1992) 0.78
Distinct roles for sphingolipids and glycosphingolipids at different stages of neuronal development. Acta Biochim Pol (1998) 0.78
Alpha-interferon: differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hematopoietic progenitor cells. J Interferon Res (1986) 0.77
Induction of cell differentiation in Burkitt lymphoma lines. BLA: a glycolipid marker of B-cell differentiation. Int J Cancer (1985) 0.76
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem (1987) 3.71
The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip-associated event involving the C-terminal region of the structural pilin subunit. Mol Microbiol (1994) 1.91
Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem (1989) 1.88
Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem (1993) 1.72
Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor. J Cell Biol (1996) 1.67
Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. Proc Natl Acad Sci U S A (1998) 1.59
Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem (1991) 1.53
Acidic pH changes receptor binding specificity of Helicobacter pylori: a binary adhesion model in which surface heat shock (stress) proteins mediate sulfatide recognition in gastric colonization. Infect Immun (1996) 1.49
Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int Immunol (1990) 1.45
Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc Natl Acad Sci U S A (1992) 1.43
Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochemistry (1992) 1.36
Identification of the key protein for zinc uptake in Hemophilus influenzae. J Biol Chem (1997) 1.36
Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem (1987) 1.34
Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res (1993) 1.31
Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun (1993) 1.31
Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc Natl Acad Sci U S A (1990) 1.27
Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro. Infect Immun (1993) 1.25
Phosphatidylethanolamine recognition promotes enteropathogenic E. coli and enterohemorrhagic E. coli host cell attachment. Microb Pathog (1999) 1.25
Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J Biol Chem (1994) 1.21
Characterization of an acidic-pH-inducible stress protein (hsp70), a putative sulfatide binding adhesin, from Helicobacter pylori. Infect Immun (1998) 1.19
Enterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet. Infect Immun (2000) 1.09
Interaction of verotoxin 2e with pig intestine. Infect Immun (1996) 1.08
Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin-layer chromatogram overlay procedures. Anal Biochem (1992) 1.07
Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol (1998) 1.05
Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells. J Neurooncol (1998) 1.04
Members of the 70 kDa heat shock protein family specifically recognize sulfoglycolipids: role in gamete recognition and mycoplasma-related infertility. J Cell Physiol (1995) 1.04
Capping and receptor-mediated endocytosis of cell-bound verotoxin (Shiga-like toxin). 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization. J Cell Physiol (1994) 1.02
Selective inhibition of cell growth and associated changes in glycolipid metabolism induced by monovalent antibodies to glycolipids. Exp Cell Res (1977) 1.01
Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili. Infect Immun (2001) 1.00
Chlamydia trachomatis and Chlamydia pneumoniae bind specifically to phosphatidylethanolamine in HeLa cells and to GalNAc beta 1-4Gal beta 1-4GLC sequences-found in asialo-GM1 and asial-GM2. Biochem Biophys Res Commun (1991) 1.00
The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc Natl Acad Sci U S A (1995) 0.98
Physicochemical evidence that Treponema pallidum TroA is a zinc-containing metalloprotein that lacks porin-like structure. J Bacteriol (1999) 0.96
A model of cell cycle control: effects of thymidine on synchronous cell cultures. Cell (1975) 0.96
Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by recombinant prokaryotic and eukaryotic hsp70 family members. Biochemistry (2001) 0.96
Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. Chem Biol (1996) 0.93
Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. J Infect Dis (1998) 0.92
Susceptibility to verotoxin as a function of the cell cycle. J Cell Physiol (1992) 0.91
Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes. Glycoconj J (1996) 0.91
Growth inhibition of murine tumor cells, in vitro, by puromycin, ( 6 N)O 2 '-dibutyryl 3',5'-adenosine monophosphate, or adenosine: evidence of commitment for cell division. J Cell Biol (1973) 0.91
Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias. Oncol Res (1997) 0.91
The preparation of rabbit antiserum specific for mammalian testicular sulfogalactoglycerolipid. J Immunol (1980) 0.90
Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin. Infect Immun (1995) 0.90
CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis. J Cell Physiol (1998) 0.90
A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol Lett (1999) 0.89
Lipid modulation of glycolipid receptor function. Availability of Gal(alpha 1-4)Gal disaccharide for verotoxin binding in natural and synthetic glycolipids. Eur J Biochem (1994) 0.89
Role of a gamete-specific sulfoglycolipid immobilizing protein on mouse sperm-egg binding. Dev Biol (1993) 0.89
Enteropathogenic Escherichia coli virulence factor bundle-forming pilus has a binding specificity for phosphatidylethanolamine. Infect Immun (2001) 0.88
Lack of specificity of current anti-digoxin antibodies, and preparation of a new, specific polyclonal antibody that recognizes the carbohydrate moiety of digoxin. Clin Chem (1985) 0.87
Recruitment of renal tubular epithelial cells expressing verotoxin-1 (Stx1) receptors in HIV-1 transgenic mice with renal disease. Kidney Int (1999) 0.87
Universal method for the facile production of glycolipid/lipid matrices for the affinity purification of binding ligands. Anal Biochem (1994) 0.86
Receptor affinity purification of a lipid-binding adhesin from Haemophilus influenzae. J Infect Dis (1997) 0.86
Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3). Int J Biol Macromol (1995) 0.86
Heat-inducible surface stress protein (Hsp70) mediates sulfatide recognition of the respiratory pathogen Haemophilus influenzae. Infect Immun (2001) 0.85
Sulfogalactolipid binding protein SLIP 1: a conserved function for a conserved protein. J Cell Physiol (1988) 0.84
Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity. J Cell Physiol (2000) 0.84
Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: differential basis of phenotype. Arch Biochem Biophys (1991) 0.82
Globoside as a membrane receptor: a consideration of oligosaccharide communication with the hydrophobic domain. Biochemistry (1997) 0.82
Monovalent antibodies directed to transformation-sensitive membrane components inhibit the process of viral transformation. Proc Natl Acad Sci U S A (1978) 0.82
Timing of sulphogalactolipid biosynthesis in the rat testis studied by tissue autoradiography. J Cell Sci (1985) 0.81
Action of galactose oxidase on galactolipids. Can J Biochem (1979) 0.81
Adamantyl globotriaosyl ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor. Biochem Biophys Res Commun (1999) 0.81
Evidence for glycosphingolipid modification of the type 1 IFN receptor. J Immunol (1994) 0.80
Induction by sphingomyelinase of shiga toxin receptor and shiga toxin 2 sensitivity in human microvascular endothelial cells. Infect Immun (2003) 0.80
Comparison of Helicobacter mustelae and Helicobacter pylori adhesion to eukaryotic cells in vitro. Gastroenterology (1995) 0.80
Purification of the testicular galactolipid: 3'-phosphoadenosine 5'-phosphosulfate sulfotransferase. J Biol Chem (1992) 0.80
Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin. Biochim Biophys Acta (2000) 0.79
The medium is the message: glycosphingolipids and their soluble analogues. Biochim Biophys Acta (2007) 0.79
Oxidation of glycosphingolipids under basic conditions: synthesis of glycosyl "serine acids" as opposed to "ceramide acids". Precursors for neoglycoconjugates with increased ligand binding affinity. Biochemistry (1999) 0.78
Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis. Biochemistry (1999) 0.78
In vitro binding of Helicobacter pylori to monohexosylceramides. Glycoconj J (2001) 0.78
Cell biological and immunological significance of ganglioside changes associated with transformation. Adv Exp Med Biol (1980) 0.78
The expression and characterization of a putative adhesin B from H. influenzae. FEMS Microbiol Lett (1998) 0.77
A glycolipid and its associated proteins: evidence by crosslinking of human erythrocyte surface components. FEBS Lett (1980) 0.77
Role of a germ cell-specific sulfolipid-immobilizing protein (SLIP1) in mouse in vivo fertilization. Mol Reprod Dev (1992) 0.77
Colocalization of sulfogalactosylacylalkylglycerol (SGG) and its binding protein during spermatogenesis and sperm maturation. Topology of SGG defines a new testicular germ cell membrane domain. Biochem Cell Biol (1986) 0.77
Modulation in the rates of incorporation of lipid precursors during the cell cycle. J Cell Physiol (1975) 0.76
Use of fluorescent standards in protein transfer and immunoblotting. Accurate estimation of the molecular weight of immunoreactive species. Anal Biochem (1985) 0.76
A verotoxin 1 B subunit-lambda CRO chimeric protein specifically binds both DNA and globotriaosylceramide (Gb(3)) to effect nuclear targeting of exogenous DNA in Gb(3) positive cells. Exp Cell Res (2001) 0.76
Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease. Leuk Res (2000) 0.75
Rapid changes in nucleoside transport induced by growth inhibitors. Studies with neoplastic mast cells. J Cell Biol (1974) 0.75
Modulation of testicular galactolipid sulphotransferase activity by phosphorylation. Stimulation of enzyme activity in vitro by an endogenous kinase. Biochem J (1989) 0.75
Production of glycolipid affinity matrices by use of heterobifunctional crosslinking agents. J Lipid Res (1984) 0.75
A one cell-cycle delay for tumor cytostasis in vitro: effects of dibutyryl cyclic AMP or embryonic extracts on synchronized cultures of a murine tumor. J Natl Cancer Inst (1974) 0.75
Oxidation of aglycone of glycosphingolipids: serine and ceramide acid precursors for soluble glycoconjugates. Methods Enzymol (2000) 0.75
Protein-glycolipid interactions during spermatogenesis. Binding of specific germ cell proteins to sulfatoxygalactosylacylalkylglycerol, the major glycolipid of mammalian male germ cells. Can J Biochem Cell Biol (1985) 0.75
Regulation of renal sulfoglycolipid biosynthesis. Biochim Biophys Acta (1986) 0.75
Preparation of monoclonal antibody to sulfatoxygalactosylglycerolipid by in vitro immunization with a glycolipid-glass conjugate. J Immunol Methods (1985) 0.75
Isolation of antiSLIP1-reactive boar sperm P68/62 and its binding to mammalian zona pellucida. Mol Reprod Dev (1998) 0.75
Alpha-galactose based neoglycopeptides. Inhibition of verotoxin binding to globotriosylceramide. Bioorg Med Chem (1999) 0.75